The Rheumatologist
COVID-19 NewsACR Convergence
  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed
  • Home
  • Conditions
    • Rheumatoid Arthritis
    • SLE (Lupus)
    • Crystal Arthritis
      • Gout Resource Center
    • Spondyloarthritis
    • Osteoarthritis
    • Soft Tissue Pain
    • Scleroderma
    • Vasculitis
    • Systemic Inflammatory Syndromes
    • Guidelines
  • Resource Centers
    • Axial Spondyloarthritis Resource Center
    • Gout Resource Center
    • Psoriatic Arthritis Resource Center
    • Rheumatoid Arthritis Resource Center
    • Systemic Lupus Erythematosus Resource Center
  • Drug Updates
    • Biologics & Biosimilars
    • DMARDs & Immunosuppressives
    • Topical Drugs
    • Analgesics
    • Safety
    • Pharma Co. News
  • Professional Topics
    • Ethics
    • Legal
    • Legislation & Advocacy
    • Career Development
      • Certification
      • Education & Training
    • Awards
    • Profiles
    • President’s Perspective
    • Rheuminations
    • Interprofessional Perspective
  • Practice Management
    • Billing/Coding
    • Quality Assurance/Improvement
    • Workforce
    • Facility
    • Patient Perspective
    • Electronic Health Records
    • Apps
    • Information Technology
    • From the College
    • Multimedia
      • Audio
      • Video
  • Resources
    • Issue Archives
    • ACR Convergence
      • Gout Resource Center
      • Axial Spondyloarthritis Resource Center
      • Psoriatic Arthritis
      • Abstracts
      • Meeting Reports
      • ACR Convergence Home
    • American College of Rheumatology
    • ACR ExamRheum
    • Research Reviews
    • ACR Journals
      • Arthritis & Rheumatology
      • Arthritis Care & Research
      • ACR Open Rheumatology
    • Rheumatology Image Library
    • Treatment Guidelines
    • Rheumatology Research Foundation
    • Events
  • About Us
    • Mission/Vision
    • Meet the Authors
    • Meet the Editors
    • Contribute to The Rheumatologist
    • Subscription
    • Contact
  • Advertise
  • Search
You are here: Home / Articles / Trump Seeks to Base Medicare Drug Prices on Lower Overseas Rates

Trump Seeks to Base Medicare Drug Prices on Lower Overseas Rates

October 25, 2018 • By Reuters Staff

  • Tweet
  • Email
Print-Friendly Version / Save PDF

WASHINGTON (Reuters)—U.S. President Donald Trump said on Thursday his administration is seeking to lower prescription drug prices by determining the price the government’s Medicare program pays for some medications based on the lower prices paid in other countries.

You Might Also Like
  • Sen. Sanders, Rep. Cummings to Introduce Bill to Lower U.S. Drug Prices
  • Trump Administration Proposes Medicare Rules Aimed at Opioids, Drug Costs
  • Trump Says Drug Companies to Announce “Massive” Price Cuts Soon
Also By This Author
  • CVS to Prevent Stockpiling of Malaria Drug Amid COVID-19

Trump said the move takes aim at what he characterized as “global freeloading” on prescription drugs.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

“The world reaps the benefit of American genius,” Trump said, speaking at the Department of Health and Human Services’ (HHS) Humphrey Building near Capitol Hill. “Seniors, who are hit the hardest, pick up the tab.”

HHS said the proposed rule would cover most of the drugs in Medicare’s Part B, which includes expensive physician administered drugs such as infusions.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

According to HHS’s projections, if they come into effect, the rule would save $17.2 billion over five years.

“If implemented, this policy certainly would lower prices in the United States,” said Craig Garthwaite, director of the healthcare program at Northwestern University’s Kellogg School of Management. “It would increase prices in Europe by an unclear amount, so it seems like it would lower overall drug spending and innovation.”

 

ad goes here:advert-3
ADVERTISEMENT
SCROLL TO CONTINUE

Filed Under: Drug Updates Tagged With: lower overseas rates, Medicare drug prices, Medicare's Part B

You Might Also Like:
  • Sen. Sanders, Rep. Cummings to Introduce Bill to Lower U.S. Drug Prices
  • Trump Administration Proposes Medicare Rules Aimed at Opioids, Drug Costs
  • Trump Says Drug Companies to Announce “Massive” Price Cuts Soon
  • Americans Want Medicare to Help Negotiate Down Drug Prices

Simple Tasks

Learn more about the ACR’s public awareness campaign and how you can get involved. Help increase visibility of rheumatic diseases and decrease the number of people left untreated.

Visit the Simple Tasks site »

Meeting Abstracts

Browse and search abstracts from the ACR Convergence and ACR/ARP Annual Meetings going back to 2012.

Visit the Abstracts site »

American College of Rheumatology

Visit the official website for the American College of Rheumatology.

Visit the ACR »

The Rheumatologist newsmagazine reports on issues and trends in the management and treatment of rheumatic diseases. The Rheumatologist reaches 11,500 rheumatologists, internists, orthopedic surgeons, nurse practitioners, physician assistants, nurses, and other healthcare professionals who practice, research, or teach in the field of rheumatology.

About Us / Contact Us / Advertise / Privacy Policy / Terms of Use / Cookie Preferences

  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed

Copyright © 2006–2023 American College of Rheumatology. All rights reserved.

ISSN 1931-3268 (print)
ISSN 1931-3209 (online)